Stevioside Counteracts Beta-Cell Lipotoxicity without Affecting Acetyl CoA Carboxylase

Area of Science:

• Metabolic research
• Cell biology
• Endocrinology

Background:

• Chronic exposure to free fatty acids causes lipotoxicity, impairing pancreatic beta-cell function.
• Basal insulin secretion (BIS) increases while glucose-stimulated insulin secretion (GSIS) decreases during lipotoxicity.
• Acetyl CoA carboxylase (ACC) is a key sensor for nutrient-induced insulin secretion in beta-cells.

Purpose of the Study:

• To investigate if stevioside (SVS) can alleviate impaired beta-cell function during lipotoxicity.
• To determine if SVS exerts its effects by regulating ACC activity.

Main Methods:

• Isolated rat islets and INS-1E cells were exposed to palmitate to induce lipotoxicity.
• Cells were treated with varying concentrations of stevioside (SVS).
• Measurements included insulin secretion, gene expression (ACC, insulin 2, glucose transporter 2, carnitine palmitoyl transporter 1), ACC protein levels, ACC activity, and glucose uptake.

Main Results:

• Lipotoxicity was induced in rat islets and INS-1E cells by palmitate exposure.
• Stevioside (SVS) counteracted the impaired insulin secretion caused by lipotoxicity.
• SVS did not affect ACC gene expression, protein levels, activity, or glucose uptake during lipotoxicity.
• Palmitate increased carnitine palmitoyl transporter 1 gene expression, an effect not altered by SVS.

Conclusions:

• Stevioside (SVS) effectively counteracts impaired insulin secretion during lipotoxicity in pancreatic beta-cells.
• The protective effect of SVS occurs independently of alterations in ACC activity.
• SVS represents a potential therapeutic agent for conditions involving lipotoxicity-induced beta-cell dysfunction.